This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2017 Aug 10;35(23):2722.

doi: 10.1200/JCO.2017.72.6828.

Errata

No authors listed

PMID: 28783482
PMCID: PMC6162006
DOI: 10.1200/JCO.2017.72.6828

Published Erratum

Errata

No authors listed. J Clin Oncol. 2017.

. 2017 Aug 10;35(23):2722.

doi: 10.1200/JCO.2017.72.6828.

PMID: 28783482
PMCID: PMC6162006
DOI: 10.1200/JCO.2017.72.6828

No abstract available

PubMed Disclaimer

Erratum for

Phase II study of the mammalian target of rapamycin inhibitor ridaforolimus in patients with advanced bone and soft tissue sarcomas.
Chawla SP, Staddon AP, Baker LH, Schuetze SM, Tolcher AW, D'Amato GZ, Blay JY, Mita MM, Sankhala KK, Berk L, Rivera VM, Clackson T, Loewy JW, Haluska FG, Demetri GD. Chawla SP, et al. J Clin Oncol. 2012 Jan 1;30(1):78-84. doi: 10.1200/JCO.2011.35.6329. Epub 2011 Nov 7. J Clin Oncol. 2012. PMID: 22067397 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations